Thu, Jan 15, 2026 | Updated 11:10 IST
May 17, 2021
New Delhi [India], May 17 : The DRDO's new anti-COVID drug, 2-DG, reduces a patient's average recovery time by two and a half days and oxygen demand by upto 40 per cent, the union health ministry informed on Monday.
Chandigarh (Haryana) [India], May 17 : Haryana will purchase anti-COVID drug 2DG developed by DRDO for treatment of coroanvirus patients, state Health Minister Anil Vij said.
More News
New Delhi [India], May 17 : The national capital reported 4,524 fresh COVID-19 cases and 10,918 recoveries in...
New Delhi [India], May 17 : A Delhi Court on Monday remanded businessman Navneet Kalra to three days...
New Delhi [India], May 17 : A writ petition was filed before the Supreme Court on Monday seeking...